Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.15p
   
  • Change Today:
    -0.100p
  • 52 Week High: 12.15
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 697.20m
  • Volume: 2,069,657
  • Market Cap: £21.96m

Director dealings: Poolbeg Pharma co-founder raise stake

By Iain Gilbert

Date: Wednesday 25 Jun 2025

LONDON (ShareCast) - (Sharecast News) - Poolbeg Pharma revealed on Wednesday that executive chair Cathal Friel had acquired 4.0m new ordinary shares in the AIM-listed biopharmaceuticals company.
Friel, who co-founded Poolbeg, purchased the shares on Friday at an average price of 2.5p per share, for a total value of £100,000.

Following the transaction, Friel holds a total of 41.21m ordinary Poolbeg shares, representing approximately 5.91% of the company's issued share capital.

As of 1545 BST, Poolbeg shares were up 6.55% at 3.09p.





Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Record (REC)
Director name: Witte,Jan
Amount purchased: 340,171 @ 54.41p
Value: £185,087.04

Record (REC)
Director name: Heading,Richard
Amount purchased: 340,171 @ 54.41p
Value: £185,087.04

Poolbeg Pharma (POLB)
Director name: Friel,Cathal
Amount purchased: 4,000,000 @ 2.50p
Value: £100,000.00

Record (REC)
Director name: Ayles,Kevin
Amount purchased: 48,462 @ 54.41p
Value: £26,368.17

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 12,450 @ 178.16p
Value: £22,180.92

Experian (EXPN)
Director name: DeRose,Kathleen
Amount purchased: 480 @ $52.29
Value: $20,696.01

Molten Ventures (GROW)
Director name: Zimmermann,Andrew
Amount purchased: 5,871 @ 288.02p
Value: £16,909.65

Experian (EXPN)
Director name: DeRose,Kathleen
Amount purchased: 320 @ $51.80
Value: $13,668.67

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 5,000 @ 178.80p
Value: £8,940.00

Intercede Group (IGP)
Director name: Leest ,Klaas van der
Amount purchased: 5,000 @ 176.00p
Value: £8,800.00

Molten Ventures (GROW)
Director name: Zimmermann,Andrew
Amount purchased: 1,047 @ 285.04p
Value: £2,984.37

Ultimate Products (ULTP)
Director name: Dent,Chris
Amount purchased: 1,992 @ 50.18p
Value: £999.54

Cranswick (CWK)
Director name: Aldersley,Christopher
Amount purchased: 3 @ 5,327.00p
Value: £159.81

Spirent Communications (SPT)
Director name: Bell,Paula
Amount purchased: 65 @ 192.40p
Value: £125.06



Top Director Sells

Costain Group (COST)
Director name: Vaughan,Alex
Amount sold: 241,639 @ 144.00p
Value: £347,960.17

Bytes Technology Group (BYIT)
Director name: Mudd,Sam
Amount sold: 65,264 @ 499.94p
Value: £326,278.89

Costain Group (COST)
Director name: Vaughan,Alex
Amount sold: 214,285 @ 142.00p
Value: £304,284.69

Costain Group (COST)
Director name: Willis,Helen
Amount sold: 100,082 @ 142.00p
Value: £142,116.44

Picton Property Income Ltd (PCTN)
Director name: Morris ,Michael
Amount sold: 142,225 @ 80.05p
Value: £113,851.11

Bytes Technology Group (BYIT)
Director name: Mudd,Sam
Amount sold: 20,548 @ 499.94p
Value: £102,727.06

Gaming Realms (GMR)
Director name: Robert Green,Geoffrey
Amount sold: 200,000 @ 51.36p
Value: £102,720.00

Costain Group (COST)
Director name: Willis,Helen
Amount sold: 56,429 @ 144.00p
Value: £81,257.76

Picton Property Income Ltd (PCTN)
Director name: Morris ,Michael
Amount sold: 92,909 @ 80.05p
Value: £74,373.65

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 3.15p
Change Today -0.100p
% Change -3.08 %
52 Week High 12.15
52 Week Low 2.40
Volume 2,069,657
Shares Issued 697.20m
Market Cap £21.96m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average53.79% below the market average
7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average7.32% below the sector average
Price Trend
87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average87.96% below the market average
77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average77.27% below the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 29-Aug-2025

Time Volume / Share Price
16:08 37,827 @ 3.24p
16:07 3,500 @ 3.30p
16:07 2,375 @ 3.12p
14:39 16 @ 3.25p
14:35 50,000 @ 3.11p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page